HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-14FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, confirming the approval of this generic Zidovudine pro…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Phase 4]
Phase 4 trial update reporting lipid changes associated with boosted atazanavir or boosted saquinavir in HIV-infected individuals.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: PREventing Progression of Adipose Tissue Redistribution [Phase 4]
Phase 4 clinical trial update on preventing progression of adipose tissue redistribution in HIV infection; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions [Phase 1]
Phase 1 clinical trial update on a dermal HIV-1 immunization administered during antiretroviral therapy with repeated treatment interruption…
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration
Update on a completed clinical trial of the CORE Buprenorphine Project, a HIV primary care program using buprenorphine. The study included p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection
The update reports on HBV-specific T-cell immunity in individuals with HIV/HBV co-infection. The trial (NCT00476723) has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: FREE Study: Efficacy and Toxicity of Trizivir [Phase 3]
Phase 3 trial update evaluating the efficacy and toxicity of Trizivir for HIV infection.
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Hepatitis B Vaccination in HIV-infected Persons [Phase 4]
A Phase 4 clinical trial assessing Hepatitis B vaccination in HIV-infected persons has completed, reporting safety and immune response outco…
-
CLINICAL_TRIALS trial_result · 2010-05-28Clinical Trial Update: A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) [Phase 1]
This Phase 1 pharmacokinetic study evaluated whether famotidine or omeprazole alters the pharmacokinetics of raltegravir in HIV-infected pat…
-
FDA approval · 2010-05-27FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for SELZENTRY (maraviroc) filed by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV Comorbidity [NA]
Completed clinical trial evaluating peroral supplemental nutrition in patients with end-stage renal disease, with and without HIV comorbidit…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects [Phase 1]
Phase I safety study of recombinant MVA HIV multiantigen vaccine in HIV-infected subjects has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients [Phase 4]
A Phase 4 trial evaluated low-dose peginterferon-α2a for chronic hepatitis C genotypes 2 or 3 in HIV-coinfected patients; the study status i…
-
FDA approval · 2010-05-17FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (Zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2010-05-17FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM [Phase 1, Phase 2]
This clinical trial update reports completed Phase 1/2 results for the 'Many Men, Many Voices' STD/HIV prevention intervention for Black men…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women [Phase 1, Phase 2]
This clinical trial update reports Phase 1 and Phase 2 results for the Healthy Love Workshop, a behavioral HIV prevention intervention for A…
-
CLINICAL_TRIALS research · 2010-05-14Clinical Trial Update: HIV Prevention Preparedness Study
This entry reports that the HIV Prevention Preparedness Study sponsored by NIAID has completed; no results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2010-05-12Clinical Trial Update: Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
An observational non-interventional study of Aptivus (tipranavir) in HIV-infected patients has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-11Clinical Trial Update: A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) [Phase 3]
A Phase 3 trial comparing maraviroc (MK-0518) in combination with Truvada to efavirenz-based therapy in treatment-naive HIV-infected patient…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
The HIV-HEART trial completed its assessment of the frequency, severity, and progression of cardiovascular diseases in HIV-infected individu…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Injecting Drug Use Community Intervention Trial [Phase 3]
Phase 3 clinical trial evaluating a community intervention for people who inject drugs. The study targets HIV, Hepatitis C, syphilis, and HS…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care [NA]
This document reports on a completed clinical trial evaluating a telemedicine-based home care model for people with chronic HIV infection.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC125-C223: TMC125 in HIV-1 Infected Subjects [Phase 2]
This document reports the completion of a Phase 2 study evaluating TMC125 (dapivirine) in HIV-1 infected subjects (TMC125-C223).
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629 [Phase 1]
Phase 1 pharmacokinetic study comparing controlled-release formulations of TMC114 (darunavir) and TMC41629 to an immediate-release formulati…